Handbook of Endovascular Peripheral Interventions
The current treatment of peripheral vascular disease is optimized by a collaborative approach among practitioners with expertise in vascular medicine, vascular imaging, open surgery, and endovascular intervention. The Handbook of Endovascular Peripheral I
- PDF / 7,490,268 Bytes
- 462 Pages / 360 x 576 pts Page_size
- 43 Downloads / 179 Views
Christopher D. Owens Yerem Yeghiazarians (Editors)
Handbook of Endovascular Peripheral Interventions
Editors Christopher D. Owens, M.D., M.Sc. Division of Vascular Surgery Department of Surgery University of California – San Francisco San Francisco, CA USA [email protected]
Yerem Yeghiazarians, M.D. Division of Interventional Cardiology Department of Medicine University of California – San Francisco San Francisco, CA USA [email protected]
ISBN 978-1-4614-0838-3 e-ISBN 978-1-4614-0839-0 DOI 10.1007/978-1-4614-0839-0 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2011943616 © Springer Science+Business Media, LLC 2012 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Foreword
Over the last decade, the field of peripheral vascular disease has seen a dramatic evolution – with an ever-expanding array of treatment options, and a growing interest among diverse medical practitioners as well as commercial entities. At the same time, the global scope of the problem continues to increase in magnitude. It is estimated that between 8 and 12 Americans harbor symptomatic or occult peripheral artery disease (PAD). While some risk factors, such as smoking and hyperlipidemia, have been targeted productively by education, public policy, and improved medications, others such as diabetes, obesity, and physical inactivity appear to be increasing in an ominous fashion. The continued aging of the population alone has major implications, as PAD prevalence is directly related to age and the disease affects as many as one in five individuals over age 65. The worldwide diabetes epidemic – recently estimated to afflict more than 23 million Americans and roughly 300 million worldwide – portends a growing burden of PAD on public health. For all vascular specialists, the treatment of PAD will dominate clinical practice demands for the foreseeable future. Yet in no other area
Data Loading...
